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in Idiopathic Constrictive Pericarditis
pTo the Editor: Chronic and permanent constrictive pericarditis
epresents a serious hemodynamic syndrome that can lead to heart
ailure unless surgically treated (1). Although a number of factors
ay cause constriction, idiopathic constrictive pericarditis (ICP) is
ecoming increasingly prevalent in developed countries (2). Un-
ortunately, the mechanisms underlying pericardial fibrosis and
alcification in ICP remain poorly understood.
Transforming growth factor-1 (TGF-1) plays a key role in
any fibrocalcific lesions, including cardiovascular diseases (3).
ere, using immunoblotting, we found increased expression of
GF-1 in ICP pericardia (n 18), and this increased expression
as associated with increased collagen/elastin ratio (r  0.6585,
Figure 1 TGF-1–Induced Calcified Nodules Formation in Conflu
(A) Apoptosis was assessed by flow cytometry. (B) The formation of calcified n
squares indicate regions of higher magnification in the respective insets. Smal
and 200 m [B8 and B10]). The alkaline phosphatase (ALP) activity (C) and ca
 SD or median (quartile 1 to quartile 3). The box ends are the 25th and 75th
ers. *p  0.05 versus transforming growth factor (TGF)-1-untreated cells; ana
FITC  fluorescein isothiocyanate. 0.0030) and calcification (rs 0.5328, p  0.0228), suggest-
ing a possible contribution of TGF-1 to pericardial fibrosis and
calcification. Real-time reverse transcription–polymerase chain
reaction (RT-PCR) demonstrated that the messenger ribonucleic
acid (mRNA) levels of collagen I, collagen III, matrix metallopro-
teinase (MMP)-2, MMP-8, MMP-9, tissue inhibitor of metallo-
proteinase (TIMP)-1, and TIMP-2 were significantly increased in
ICP (n  18) pericardia compared with control pericardia (n  12),
whereas those of elastin, MMP-1, and MMP-13 were decreased
(all p  0.05). Subsequently, ICP pericardia (n  43, including
additional 25 archived specimens) were processed for histological
analysis; fibrosis was detected in 43 of 43 (100%) cases and
PICs
s in confluent pericardial interstitial cells (PICs) was monitored. The white
s (B7, B8, B9) indicate apoptosis. (Bar  100 m [B1 through B7 and B9]
deposition (D) were quantified colorimetrically. Data are presented as mean
ntiles; whiskers indicate the minimum and maximum values, excluding outli-
in A by Wilcoxon rank-sum test, in C and D by unpaired Student t test.ent
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April 12, 2011:1634–9calcification in 34 of 43 (79%). Ossification was seen in 5 of 34
(15%) calcified pericardia. The study was approved by the local
ethics committee, and all of the patients gave informed consent.
We isolated pericardial interstitial cells (PICs) and found that
they possessed a similar immunophenotype as mesenchymal stem
cells. The PICs differentiated into myofibroblasts, chondroblasts,
and osteoblasts after stimulation with TGF-1, indicating that
GF-1 may promote abnormal differentiation of adult PICs and
ead to biological changes.
The effects of TGF-1 on PICs were consistent with the
hanges in fibrosis-related genes (compared to control baseline
alues) in ICP pericardia as mentioned in the preceding text.
ncubation of PICs with TGF-1 (10 to 60 ng/ml) for 48 h or
with 10 ng/ml TGF-1 for 6 to 48 h increased the mRNA
xpression of collagen I and collagen III in a concentration- and
ime-dependent manner. After PICs were treated with TGF-1
(10 ng/ml) for 48 h, MMP-2 and -9 mRNA, critical for elastin
degradation, were increased by 5.19-fold and 2.68-fold, respec-
tively. The TIMP-2 mRNA, a natural inhibitor for MMP-2, was
also increased by 25.48-fold. However, TGF-1 decreased the
RNA levels of MMP-1 (57%) and MMP-13 (53%) in PICs
nd increased that of MMP-8 by 6.22-fold. Three days after
GF-1 (10 ng/ml) stimulation, zymography of conditioned
edia revealed a band of gelatin degradation at 130 kDa, which
epresents the heterodimer of MMP-9 and neutrophil gelatinase-
ssociated lipocalin. Heterodimer can prevent MMP-9 degrada-
ion, thereby augmenting MMP-9 activity. However, gelatinolytic
and of MMP-2 was not detectable until day 28, indicating that
GF-1–induced robust transcription of TIMP-2 inhibits the
ctivity of MMP-2.
We found TGF-1 may also contribute to the progression of
alcification by inducing apoptosis and osteogenic differentiation
f PICs. The TGF-1 treatment (10 ng/ml, 48 h) resulted in a
.8-fold increase in apoptosis of confluent PICs compared with
ntreated cells (Fig. 1A). After treatment with TGF-1 (10
g/ml), confluent PICs (Fig. 1B1) spontaneously retracted from
eighboring areas (Fig. 1B2) and grouped into aggregates
Fig. 1B3). With the formation of nodules (Fig. 1B4), cells became
enser in the central areas of the nodules (Fig. 1B5) and expressed
lkaline phosphatase (osteoblast marker) (Fig. 1B6). Propidium
odide counterstaining (Fig. 1B7) showed that a proportion of cells
xhibited nuclear shrinkage and chromatin condensation. Termi-
al deoxynucleotidyl transferase–mediated dUTP nick-end label-
ng (TUNEL) staining (Fig. 1B8) confirmed the presence of
poptosis. Hoechst 33342 and propidium iodide double staining
Fig. 1B9) revealed a number of cells had already died by apoptosis.
on Kossa staining (Fig. 1B10) detected calcium deposition in the
odules. These nodules displayed increased alkaline phosphatase
ctivity (sevenfold) (Fig. 1C) and contained more calcium (6-fold)
Fig. 1D) than TGF-1-untreated cells.
In conclusion, our results demonstrate that TGF-1 exerts
leiotropic effects on PICs by promoting abnormal differentiation,
nducing apoptosis, and regulating the expression of fibrosis-
elated genes in PICs, which indicates that TGF-1 may act as a
egulator of both fibrosis and calcification during the progression
f ICP.
iaohong Liu, MD, PhD
henguang Bai, MD, PhD
ejun Gong, BSc
ang Yuan, BScLin Han, MD, PhD
Fanglin Lu, MD, PhD
Qinqi Han, MD, PhD
Hao Tang, MD, PhD
Shengdong Huang, MD, PhD
*Zhiyun Xu, MD, PhD
*Institute of Cardiothoracic Surgery
Changhai Hospital
168 Changhai Road
Shanghai 200433
People’s Republic of China
E-mail: drzhiyunxu@gmail.com
doi:10.1016/j.jacc.2010.10.054
lease note: Drs. Liu and Bai are both first authors. Supported by a grant (30700809)
rom the National Natural Science Foundation of China. The authors have reported
hat they have no relationships to disclose.
EFERENCES
1. Little WC, Freeman GL. Pericardial disease. Circulation 2006;113:
1622–32.
2. Bertog SC, Thambidorai SK, Parakh K, et al. Constrictive pericarditis:
etiology and cause-specific survival after pericardiectomy. J Am Coll
Cardiol 2004;43:1445–52.
3. Simionescu A, Simionescu DT, Vyavahare NR. Osteogenic responses
in fibroblasts activated by elastin degradation products and transforming
growth factor-beta1: role of myofibroblasts in vascular calcification.
Am J Pathol 2007;171:116–23.
Letters to the Editor
Clinical Outcome, Angiographic
Outcome, and Coronary
Endothelial Function After
Drug-Eluting Stent Implantation
I read with interest the paper by Park et al. (1) comparing patients
treated with zotarolimus-eluting stents (ZES) with patients
treated with paclitaxel-eluting stents (PES) or sirolimus-eluting
stents in routine clinical practice. Although the authors dem-
onstrated that ischemia-driven target lesion revascularization
and target vessel revascularization at 12 months were signifi-
cantly more reduced in the ZES group than in the PES group
(4.9% vs. 7.5% and 5.2% vs. 7.6%, respectively, see Table 3 of
Park et al. [1]), quantitative angiographic analysis (Table 4 of
Park et al. [1]) demonstrated no significant differences in binary
restenosis between the groups (in stent, 9.6% vs. 10.9%; in
segment, 12.1% vs. 12.4%, respectively) as well as in other
angiographic variables (minimal luminal diameter and percent-
age of diameter stenosis).
Previous studies demonstrated that endothelial function of the
implanted vessel was preserved in patients treated with ZES (2–4),
whereas endothelial dysfunction was observed in vessels treated
with PES (3,5–7). Patients with ZES restenosis may present with
angina or ischemia less frequently than patients with PES reste-
nosis, even with a similar degree of stenosis. To clarify this point,
